Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline effects on reward processing in healthy volunteers
NCT04130087Unknown
- Sponsor
- University of Oxford
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Selegiline Group with Placebo Group (2 arms). Primary endpoints: Total monetary amount won in reward learning task, Reaction times in reward learning task and 1 more. Status: unknown.
02
Drugs
selegiline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04130087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130087.